John Greisch, chief executive of Hill-Rom Holdings Inc, has been nominated to the board of Actelion Ltd of Switzerland, which has a drug for pulmonary arterial hypertension on the market. Mr Greisch also spent seven years at Baxter International Inc in corporate finance, operations and general management. He holds a Bachelor’s degree in Business Administration from Miami University and a Master’s Degree in Management from Northwestern University, both in the US.
Actelion announced the appointments on 14 March 2013.
Copyright 2013 Evernow Publishing Ltd.